{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T00:19:24Z","timestamp":1788826764834,"version":"build-2803163510"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1177\/1933719115584448","type":"journal-article","created":{"date-parts":[[2015,5,12]],"date-time":"2015-05-12T01:02:39Z","timestamp":1431392559000},"page":"1445-1451","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Effects of Pazopanib, Sunitinib, and Sorafenib, Anti-VEGF Agents, on the Growth of Experimental Endometriosis in Rats"],"prefix":"10.1007","volume":"22","author":[{"given":"Caglar","family":"Yildiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Turgut","family":"Kacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozlem Bozoklu","family":"Akkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savas","family":"Karakus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selen Baloglu","family":"Kacan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hatice","family":"Ozer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,12,30]]},"reference":[{"key":"22111445_CR1","volume-title":"Pathogenesis, Clinical Features, and Diagnosis of Endometriosis","author":"RS Schenken","year":"2014","unstructured":"Schenken RS. Pathogenesis, Clinical Features, and Diagnosis of Endometriosis. Waltham, MA: UpToDate; 2014."},{"key":"22111445_CR2","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1477-7827-12-50","volume":"12","author":"YB Aznaurova","year":"2014","unstructured":"Aznaurova YB, Zhumataev MB, Roberts TK, Aliper AM, Zhavoronkov AA. Molecular aspects of development and regulation of endometriosis. Reprod Biol Endocrinol. 2014;12:50.","journal-title":"Reprod Biol Endocrinol"},{"issue":"10","key":"22111445_CR3","doi-asserted-by":"publisher","first-page":"e76808","DOI":"10.1371\/journal.pone.0076808","volume":"8","author":"S Matsuzaki","year":"2013","unstructured":"Matsuzaki S, Darcha C. Involvement of the Wnt\/\u03b2-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis. PLoS One. 2013;8(10):e76808.","journal-title":"PLoS One"},{"issue":"3","key":"22111445_CR4","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1056\/NEJMra0804690","volume":"360","author":"SE Bulun","year":"2009","unstructured":"Bulun SE. Endometriosis. N Engl J Med. 2009;360(3):268\u2013279.","journal-title":"N Engl J Med."},{"key":"22111445_CR5","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.ejogrb.2014.10.038","volume":"183","author":"J Cohen","year":"2014","unstructured":"Cohen J, Naoura I, Castela M, et al. Pregnancy affects morphology of induced endometriotic lesions in a mouse model through alteration of proliferation and angiogenesis. Eur J Obstet Gynecol Reprod Biol. 2014;183:70\u201377.","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"22111445_CR6","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1749-6632.2002.tb02769.x","volume":"955","author":"RN Taylor","year":"2002","unstructured":"Taylor RN, Lebovic DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci. 2002;955:89\u2013100.","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"22111445_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jri.2004.09.002","volume":"65","author":"C Uzan","year":"2005","unstructured":"Uzan C, Cortez A, Dufournet C, et al. Endometrium from women with and without endometriosis, and peritoneal, ovarian and bowel endometriosis, show different c-kit protein expression. J Reprod Immunol. 2005;65(1):55\u201363.","journal-title":"J Reprod Immunol"},{"issue":"3","key":"22111445_CR8","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.fertnstert.2010.10.029","volume":"95","author":"A Pacchiarotti","year":"2011","unstructured":"Pacchiarotti A, Caserta D, Sbracia M, et al. Expression of oct-4 and c-kit antigens in endometriosis. Fertil Steril. 2011;95(3): 1171\u20131173.","journal-title":"Fertil Steril"},{"issue":"3","key":"22111445_CR9","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/s10495-014-1079-8","volume":"20","author":"GA Gon\u00e7alves","year":"2015","unstructured":"Gon\u00e7alves GA, Camargo-Kosugi CM, Bonetti TC, et al. p27kip1 overexpression regulates VEGF expression, cell proliferation and apoptosis in cell culture from eutopic endometrium of women with endometriosis. Apoptosis. 2015;20(3):327\u2013335.","journal-title":"Apoptosis"},{"issue":"9","key":"22111445_CR10","first-page":"1129","volume":"29","author":"HS Abdalla Ribeiro","year":"2014","unstructured":"Abdalla Ribeiro HS, Galv\u0101o MA, Aoki T, Aldrighi JM, Ribeiro PA. Anti-apoptotic activity in deep pelvic endometriosis. Histol Histopathol. 2014;29(9):1129\u20131133.","journal-title":"Histol Histopathol."},{"issue":"2-3","key":"22111445_CR11","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.mvr.2007.04.008","volume":"74","author":"CM Becker","year":"2007","unstructured":"Becker CM, D\u2019Amato RJ. Angiogenesis and antiangiogenic therapy in endometriosis. Microvasc Res. 2007;74(2\u20133):121\u2013130.","journal-title":"Microvasc Res."},{"issue":"1","key":"22111445_CR12","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/humupd\/6.1.45","volume":"6","author":"J McLaren","year":"2000","unstructured":"McLaren J. Vascular endothelial growth factor and endometriotic angiogenesis. Hum Reprod Update. 2000;6(1):45\u201355.","journal-title":"Hum Reprod Update"},{"issue":"3","key":"22111445_CR13","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s10456-013-9333-1","volume":"16","author":"H Xu","year":"2013","unstructured":"Xu H, Zhang T, Man GC, et al. Vascular endothelial growth factor C is increased in endometrium and promotes endothelial functions, vascular permeability and angiogenesis and growth of endometriosis. Angiogenesis. 2013;16(3):541\u2013551.","journal-title":"Angiogenesis"},{"issue":"12","key":"22111445_CR14","first-page":"1324","volume":"9","author":"B Sloan","year":"2008","unstructured":"Sloan B, Scheinfeld NS. Pazopanib, a VEGF receptor tyrosine kinase inhibitor for cancer therapy. Curr Opin Investig Drugs. 2008;9(12):1324\u20131335.","journal-title":"Curr Opin Investig Drugs."},{"issue":"2","key":"22111445_CR15","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.bbrc.2007.02.156","volume":"356","author":"R Roskoski Jr","year":"2007","unstructured":"Roskoski R Jr. Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor. Biochem Biophys Res Commun. 2007;356(2):323\u2013328.","journal-title":"Biochem Biophys Res Commun."},{"issue":"10","key":"22111445_CR16","doi-asserted-by":"publisher","first-page":"3129","DOI":"10.1158\/1535-7163.MCT-08-0013","volume":"7","author":"SM Wilhelm","year":"2008","unstructured":"Wilhelm SM, Adnane L, Newell P, Villanueva A, Llovet JM, Lynch M. Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling. Mol Cancer Ther. 2008;7(10):3129\u20133140.","journal-title":"Mol Cancer Ther."},{"issue":"3","key":"22111445_CR17","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1158\/1541-7786.MCR-06-0404","volume":"5","author":"J Tabernero","year":"2007","unstructured":"Tabernero J. The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents. Mol Cancer Res. 2007;5(3):203\u2013220.","journal-title":"Mol Cancer Res."},{"issue":"6","key":"22111445_CR18","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.fertnstert.2012.08.003","volume":"98","author":"A Moggio","year":"2012","unstructured":"Moggio A, Pittatore G, Cassoni P, Marchino GL, Revelli A, Bussolati B. Sorafenib inhibits growth, migration, and angiogenic potential of ectopic endometrial mesenchymal stem cells derived from patients with endometriosis. Fertil Steril. 2012;98(6):1521\u20131530.","journal-title":"Fertil Steril"},{"issue":"1","key":"22111445_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1177\/1933719112452941","volume":"20","author":"H Ozer","year":"2013","unstructured":"Ozer H, Boztosun A, Ac\u00b8maz G, Atilgan R, Akkar OB, Kosar MI. The efficacy of bevacizumab, sorafenib, and retinoic acid on rat endometriosis model. Reprod Sci. 2013;20(1):26\u201332.","journal-title":"Reprod Sci."},{"issue":"4","key":"22111445_CR20","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ejps.2013.05.021","volume":"49","author":"MA Abbas","year":"2013","unstructured":"Abbas MA, Disi AM, Taha MO. Sunitinib as an anti-endometriotic agent. Eur J Pharm Sci. 2013;49(4):732\u2013736.","journal-title":"Eur J Pharm Sci."},{"key":"22111445_CR21","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1756-9966-29-4","volume":"29","author":"DE Machado","year":"2010","unstructured":"Machado DE, Berardo PT, Palmero CY, Nasciutti LE. Higher expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 (Flk-1) and metalloproteinase-9 (MMP-9) in a rat model of peritoneal endometriosis is similar to cancer diseases. J Exp Clin Cancer Res. 2010;29:4.","journal-title":"J Exp Clin Cancer Res."},{"issue":"1","key":"22111445_CR22","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.jri.2012.10.012","volume":"97","author":"AK Edwards","year":"2013","unstructured":"Edwards AK, Nakamura DS, Virani S, Wessels JM, Tayade C. Animal models for anti-angiogenic therapy in endometriosis. J Reprod Immunol. 2013;97(1):85\u201394.","journal-title":"J Reprod Immunol"},{"issue":"5","key":"22111445_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/S0015-0282(16)48988-0","volume":"44","author":"MW Vernon","year":"1985","unstructured":"Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684\u2013694.","journal-title":"Fertil Steril"},{"issue":"1","key":"22111445_CR24","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/S0015-0282(99)00157-0","volume":"72","author":"JA Keenan","year":"1999","unstructured":"Keenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudle MR, Bukovsky A. Regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril. 1999;72(1):135\u2013141.","journal-title":"Fertil Steril"},{"issue":"6","key":"22111445_CR25","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1093\/humrep\/13.6.1686","volume":"13","author":"J Donnez","year":"1998","unstructured":"Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod. 1998;13(6):1686\u20131690.","journal-title":"Hum Reprod"},{"issue":"3","key":"22111445_CR26","first-page":"138","volume":"8","author":"W Remmele","year":"1987","unstructured":"Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estrogen receptor detection (ER-ICA) in breast cancer tissue. Pathologe. 1987;8(3):138\u2013140.","journal-title":"Pathologe."},{"issue":"11","key":"22111445_CR27","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.humpath.2004.07.020","volume":"35","author":"M Takehara","year":"2004","unstructured":"Takehara M, Ueda M, Yamashita Y, Terai Y, Hung YC, Ueki M. Vascular endothelial growth factor A and C gene expression in endometriosis. Hum Pathol. 2004;35(11):1369\u20131375.","journal-title":"Hum Pathol"},{"issue":"1","key":"22111445_CR28","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1210\/edrv.18.1.0287","volume":"18","author":"N Ferrara","year":"1997","unstructured":"Ferrara N, Davis-Smyth T. The biology of vascular endothelial growth factor. Endocr Rev. 1997;18(1):4\u201325.","journal-title":"Endocr Rev."},{"key":"22111445_CR29","first-page":"15","volume":"55","author":"N Ferrara","year":"2000","unstructured":"Ferrara N. Vascular endothelial growth factor and the regulation of angiogenesis. Recent Prog Horm Res. 2000;55:15\u201335.","journal-title":"Recent Prog Horm Res."},{"issue":"2","key":"22111445_CR30","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10456-005-9005-x","volume":"8","author":"PG Groothuis","year":"2005","unstructured":"Groothuis PG, Nap AW, Winterhager E, Gr\u00fcmmer R. Vascular development in endometriosis. Angiogenesis. 2005;8(2): 147\u2013156.","journal-title":"Angiogenesis"},{"issue":"11","key":"22111445_CR31","first-page":"7752","volume":"7","author":"WW Song","year":"2014","unstructured":"Song WW, Lu H, Hou WJ, et al. Expression of vascular endothelial growth factor C and anti-angiogenesis therapy in endometriosis. Int J Clin Exp Pathol. 2014;7(11):7752\u20137759.","journal-title":"Int J Clin Exp Pathol"},{"issue":"3","key":"22111445_CR32","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.fertnstert.2012.06.029","volume":"98","author":"RO Burney","year":"2012","unstructured":"Burney RO, Giudice LC. Pathogenesis and pathophysiology of endometriosis. Fertil Steril. 2012;98(3):511\u2013519.","journal-title":"Fertil Steril"},{"issue":"2","key":"22111445_CR33","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1177\/1933719108324893","volume":"16","author":"RN Taylor","year":"2009","unstructured":"Taylor RN, Yu J, Torres PB, et al. Mechanistic and therapeutic implications of angiogenesis in endometriosis. Reprod Sci. 2009;16(2):140\u2013146.","journal-title":"Reprod Sci."},{"issue":"5","key":"22111445_CR34","doi-asserted-by":"publisher","first-page":"435","DOI":"10.7150\/ijbs.6087","volume":"9","author":"J Liang","year":"2013","unstructured":"Liang J, Wu YL, Chen BJ, Zhang W, Tanaka Y, Sugiyama H. The C-kit receptor-mediated signal transduction and tumor-related diseases. Int J Biol Sci. 2013;9(5):435\u2013443.","journal-title":"Int J Biol Sci."},{"issue":"3","key":"22111445_CR35","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1177\/1933719110392059","volume":"18","author":"K Nasu","year":"2011","unstructured":"Nasu K, Nishida M, Kawano Y, et al. Aberrant expression of apoptosis-related molecules in endometriosis: a possible mechanism underlying the pathogenesis of endometriosis. Reprod Sci. 2011;18(3):206\u2013218.","journal-title":"Reprod Sci."},{"issue":"11","key":"22111445_CR36","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1517\/14656566.2014.920824","volume":"15","author":"A Shablak","year":"2014","unstructured":"Shablak A, Gilham DE, Hawkins RE, Elkord E. In vitro effect of IL-2 in combination with pazopanib or sunitinib on lymphocytes function and apoptosis of RCC cells. Expert Opin Pharmacother. 2014;15(11):1489\u20131499.","journal-title":"Expert Opin Pharmacother"},{"issue":"5","key":"22111445_CR37","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s00280-006-0393-4","volume":"59","author":"YS Chang","year":"2007","unstructured":"Chang YS, Adnane J, Trail PA, et al. Sorafenib (BAY 43\u20139006) inhibits tumor growth and vascularization and induces tumor apoptosis and hypoxia in RCC xenograft models. Cancer Che-mother Pharmacol. 2007;59(5):561\u2013574.","journal-title":"Cancer Che-mother Pharmacol"},{"key":"22111445_CR38","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/1471-2407-11-28","volume":"11","author":"XD Zhu","year":"2011","unstructured":"Zhu XD, Zhang JB, Fan PL, et al. Antiangiogenic effects of pazopanib in xenograft hepatocellular carcinoma models: evaluation by quantitative contrast-enhanced ultrasonography. BMC Cancer. 2011;11:28.","journal-title":"BMC Cancer"},{"key":"22111445_CR39","doi-asserted-by":"crossref","unstructured":"Ishijima N, Kanki K, Shimizu H, Shiota G. AMPK activation by retinoic acid sensitizes hepatocellular carcinoma cells to apoptosis induced by sorafenib[published online February 12, 2015]. Cancer Sci. 2015. doi:10.1111\/cas.12633.","DOI":"10.1111\/cas.12633"},{"key":"22111445_CR40","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/2045-824X-6-12","volume":"6","author":"E Chinchar","year":"2014","unstructured":"Chinchar E, Makey KL, Gibson J, et al. Sunitinib significantly suppresses the proliferation, migration, apoptosis resistance, tumor angiogenesis and growth of triple-negative breast cancers but increases breast cancer stem cells. Vasc Cell. 2014;6:12.","journal-title":"Vasc Cell"},{"issue":"9","key":"22111445_CR41","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1210\/jc.2013-1364","volume":"98","author":"T Di Desidero","year":"2013","unstructured":"Di Desidero T, Fioravanti A, Orlandi P, et al. Antiproliferative and proapoptotic activity of sunitinib on endothelial and anaplastic thyroid cancer cells via inhibition of Akt and ERK1\/2 phosphorylation and by down-regulation of cyclin-D1. J Clin Endocrinol Metab. 2013;98(9):1465\u20131473.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115584448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719115584448","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719115584448\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719115584448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719115584448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T01:39:56Z","timestamp":1656812396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719115584448"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":41,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["22111445"],"URL":"https:\/\/doi.org\/10.1177\/1933719115584448","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"30 December 2015","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}